Debulking surgery (ovarian/peritoneal cancers) in Lahore

What it is

Debulking surgery, also called cytoreductive surgery, removes as much cancer tissue as possible from the ovaries, the lining of the abdomen and nearby organs. It is a main treatment for advanced ovarian and peritoneal cancers and usually works together with chemotherapy.

How the procedure works

Most debulking operations are done through an open incision in the abdomen so the surgeon can see and reach every deposit of disease. In selected earlier cases a keyhole or robotic approach may be possible, and Dr. Shehryar Niazi chooses the safest route for each patient.

Benefits

Maximum safe removal of visible cancer
Better response to chemotherapy afterwards
One planned operation by an experienced surgical team

Who it is for

Debulking surgery suits patients with confirmed ovarian or peritoneal cancer where scans show tumour that can be removed safely. Fitness for a major operation is checked first, and the plan is agreed together with the wider cancer care team.

Recovery

A hospital stay of several days is normal, and most patients build back their strength over a few weeks at home. Chemotherapy often follows once the wound has healed, with regular follow-up visits to track progress.

The experience with Dr. Shehryar Niazi in Lahore

Care begins with a consultation at Farooq Hospital, DHA, where Dr. Shehryar Niazi reviews your history, explains the options and answers your questions. Surgery and follow-up are handled by the same team, so you deal with familiar faces at every step.

For more information or to book an appointment, contact the clinic on +92 310 1612820.

Frequently asked questions

What is the surgery for gynecological cancer?

Surgery for gynecological cancer removes the tumour and any tissue it has spread to, which for ovarian and peritoneal cancer often means a debulking operation. The aim is to take out as much visible disease as safely possible before or alongside chemotherapy.

How are gynecologic cancers detected?

Gynecological cancers are usually found through a mix of pelvic examination, ultrasound or CT scans and blood tests such as CA-125. A tissue sample or biopsy then confirms the diagnosis and guides the treatment plan.

What are the risk factors for gynecological cancer?

Common risk factors include older age, a family history of ovarian or breast cancer, and inherited gene changes such as BRCA. Other factors can include never having been pregnant, endometriosis and long-term hormonal influences.